Chelsea Women’s latest move is aimed at changing a conversation that has often remained outside the football dressing room. The club has launched a first-of-its-kind fertility fund for its women’s team, offering players access to personalised fertility support while opening a wider discussion about reproductive health in elite sport. Chelsea Women launch historic fertility fund to support players beyond football.
Chelsea FC Women have announced a new partnership with London-based Fertility Plus that will provide every player on the women’s team roster with access to dedicated fertility assessments, treatments, counselling and reproductive health education. The initiative represents another significant step in the club’s increasingly holistic approach to player welfare. The partnership goes beyond a conventional medical arrangement. At its centre is a new fertility fund designed specifically for Chelsea’s players, giving them access to bespoke support according to their individual circumstances. The services include fertility assessments, treatment options including egg freezing, counselling and educational workshops.
For elite female athletes, fertility can present a particularly complex consideration. The peak years of sporting careers can overlap with the years in which many women may be thinking about starting a family. Chelsea’s new initiative seeks to ensure players are not forced to view professional ambition and reproductive choices as competing priorities. The club has increasingly placed women’s health at the centre of its player-care strategy. Chelsea previously became the first team to appoint a menstrual cycle coach, while its partnership with period-care brand Here We Flo has also sought to challenge stigma surrounding menstruation and participation in sport.
The fertility partnership therefore extends an existing philosophy rather than standing alone. A major component of the new programme will be education. Chelsea and Fertility Plus intend to provide expert-led workshops and resources designed to separate medical evidence from commonly held misconceptions surrounding fertility. According to research highlighted by Chelsea, 41% of respondents who were actively trying to conceive did not know when their fertile window was. The finding, referenced by the club from research published in Reproductive Health, underlines the knowledge gap that the partnership hopes to address.
The initiative will also extend beyond the playing squad. Chelsea and Fertility Plus plan to produce educational material for the wider Chelsea community, including myth-versus-medicine resources and expert-led content. Giulia Mazzia, commercial director for Chelsea FC Women, said: ‘At Chelsea FC Women we are never done pushing for progress for our players and our community. This first-of-its-kind partnership with Fertility Plus will open up the conversation about fertility, help to raise awareness for our incredible fanbase and beyond, and give practical support to our players off the field as well as on it.’
For Fertility Plus, the partnership addresses an issue that has historically received limited attention within elite sport. Dr Amit Shah and Dr Anil Gudi, co-founders of Fertility Plus, said: ‘Elite sport asks a lot of women during the very years when fertility matters most, yet it’s a conversation the game has rarely had. Partnering with Chelsea FC Women allows us to help change that by giving players, staff and supporters access to trusted fertility expertise and compassionate, consultant-led care. We’re proud to work alongside a club that’s setting a new standard for supporting women’s health, both on and off the pitch.’
The move comes at a time when Chelsea Women are continuing to build their profile both competitively and commercially. The club has pursued dedicated resources and commercial leadership for the women’s team as part of its broader strategic growth plan.
Chelsea’s fertility fund matters because it changes the definition of what player welfare means in women’s football. For years, elite sport has largely been structured around performance, recovery and availability. Chelsea’s latest initiative recognises that female athletes have health considerations that extend beyond matchday fitness. Providing fertility assessments, treatment support and education does not simply offer another benefit to players. It acknowledges that athletes should be able to make personal decisions about their futures without feeling that their careers have to dictate those choices.
The bigger significance may lie in the conversation this creates. Chelsea are not only providing a service to their own squad but using the visibility of one of women’s football’s biggest clubs to make reproductive health a legitimate part of the sporting discussion. After challenging taboos around menstrual health, Chelsea are now moving into another area that has traditionally been discussed privately. If other clubs follow, fertility support could gradually become a more recognised component of player welfare across women’s professional sport.
For Chelsea, the ambition is clear: success should not only be measured by trophies. It should also be measured by how well the club supports the women who compete for them.
